Defining Value-Based Pricing of Drugs Reply

被引：0
|
作者：
Kaltenboeck, Anna [1 ]
Bach, Peter B. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 485 Lexington Ave, New York, NY 10017 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 320卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1001/jama.2018.11820
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1710 / 1711
页数：2
相关论文
共 50 条
  • [1] Value-based pricing of drugs in the UK
    Webb, David J.
    Walker, Andrew
    LANCET, 2007, 369 (9571): : 1415 - 1416
  • [2] Value-Based Pricing for Drugs Theme and Variations
    Kaltenboeck, Anna
    Bach, Peter B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (21): : 2165 - 2166
  • [3] Value-Based Pricing for Drugs With Uncertain Clinical Benefits
    Jiao, Boshen
    Hsieh, Yuli Lily
    Li, Meng
    Verguet, Stephane
    HEALTH ECONOMICS, 2025, 34 (04) : 780 - 790
  • [4] Value-Based Pricing and Patient Access for Specialty Drugs
    Robinson, James C.
    Howell, Scott
    Pearson, Steven D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (21): : 2169 - 2170
  • [5] Value elements and methods of value-based pricing for drugs in Japan: a systematic review
    Takami, Akina
    Kato, Masafumi
    Deguchi, Hisato
    Igarashi, Ataru
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (07) : 749 - 759
  • [6] VALUE-BASED DIFFERENTIAL PRICING: EFFICIENT PRICES FOR DRUGS IN A GLOBAL CONTEXT
    Danzon, Patricia
    Towse, Adrian
    Mestre-Ferrandiz, Jorge
    HEALTH ECONOMICS, 2015, 24 (03) : 294 - 301
  • [7] Convergence of decision rules for value-based pricing of new innovative drugs
    Gandjour, Afschin
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (02) : 209 - 213
  • [8] Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs
    Bach, Peter B.
    Pearson, Steven D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (23): : 2503 - 2504
  • [9] A reply to "Who would benefit from average value-based pricing?"
    Levaggi, Rosella
    Pertile, Paolo
    HEALTH ECONOMICS, 2021, 30 (09) : 2284 - 2286
  • [10] Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition"
    Levaggi, Rosella
    Pertile, Paolo
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2020, 18 (03) : 455 - 456
12345